Weekly Rounds: Hot Topics in IPC, Infection Intel, Inhaled Therapies for Lung Functions, and More
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending November 5, 2023.
Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.
Hot Topics in IPC: Influenza, COVID-19, and Mechanical Ventilation and Drug-Resistant Pathogens
In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses her concerns about COVID-19 and influenza for this winter, and mechanical ventilation and drug-resistant pathogens.
Infection Intel: Chicopee, GP Pro, US FDA, and Henry Schein
Staying Ahead With Company Updates and Product Innovations. This week's news is from Chicopee, GP Pro, US FDA, and Henry Schein.
Qnovia Collaborates With UVA to Develop Novel Inhaled Therapies for Lung Infections
Pharmaceutical company Qnovia partners with the University of Virginia (UVA) to create inhaled drugs for lung infections, bolstering their development pipeline with assets for pneumonia and biodefense-related pulmonary infections.
CDC Advises on Limited Nirsevimab Supply and RSV Protection Options
The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Encouraging Results Emerge from Phase 1/2 Study of mRNA-Based Influenza and COVID-19 Combo Vaccines
With a safety profile consistent with Pfizer’s COVID-19 vaccine, this combination vaccine candidate will most likely be moving to a phase 3 trial in the coming months.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
